First New York Securities’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-20
Closed -$9.86K 444
2015
Q2
$9.86K Buy
+20
New +$9.86K ﹤0.01% 303